Preclinical Services Driving Innovation
GemPharmatech provides and expansive array of preclinical services, including mouse model customization, pharmacology services, CRISPR/Cas9 gene-editing, and customized breeding.
Largest Collection of GEMMs
We have created a collection of over 20,000+ genetically engineered mouse models (GEMMs) for research and drug development.
Cutting Edge Technology
We specialize in developing animal models using cutting edge gene-editing technologies with a large collection of cKO/KO mice, humanized mice, and immunodeficient mice.
Dedicated to Scientific Advancement
GemPharmatech is a leading provider of genetically modified mouse models and preclinical services to global R&D communities. We offer more than 20,000+ mouse models and can create new custom models based on your research needs.
Dr. Xiang Gao, Chairman of GemPharmatech Co. Ltd., was the founding director of the Model Animal Research Center (MARC) at Nanjing University. He has published more than 200 scientific articles focused on mouse models and disease research. In 2017, Dr. Gao founded GemPharmatech Co. Ltd., which is currently enlisted in the Shanghai Stock Exchange STAR Market. Dr. Mark Moore is the CEO of GemPharmatech LLC, the US subsidiary of GemPharmatech. Dr. Moore was a co-founder and CSO of Deltagen, the first high-throughput gene knockout and target development company, and later served as the Executive Director of the International Mouse Phenotyping Consortium (IMPC).
With their combined experience Dr. Gao, Dr. Moore, and the global GemPharmatech team are rapidly advancing preclinical mouse models and accelerating basic and translational research.
We’re Trusted Experts
Preclinical and model customization services
Large Collection of GEMMs
20,000+ genetically engineered mouse models
Fast, high-quality custom mouse models